ISDA AGM: BlackRock’s Kim Outlines Regulatory Drawbacks For Buyside

Regulatory proposals covering over-the-counter derivatives will bring significant costs to end users, while rules surrounding reporting requirements and collateral remain unclear and need further clarification, according to Joel Kim, head of fixed income, Asia Pacific, at BlackRock.

  • 24 Apr 2013

Regulatory proposals covering over-the-counter derivatives will bring significant costs to end users, while rules surrounding reporting requirements and collateral remain unclear and need further clarification, according to Joel Kim, head of fixed income, Asia Pacific, at BlackRock.

“From a buyside perspective, such as things like reporting requirements, yes ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 280,892.95 1037 8.97%
2 JPMorgan 256,461.06 1168 8.19%
3 Bank of America Merrill Lynch 250,468.43 865 8.00%
4 Goldman Sachs 192,174.73 616 6.14%
5 Barclays 184,453.95 705 5.89%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 28,971.26 117 7.01%
2 Deutsche Bank 27,415.35 91 6.63%
3 Bank of America Merrill Lynch 25,509.39 71 6.17%
4 BNP Paribas 21,729.97 121 5.26%
5 Credit Agricole CIB 19,966.59 113 4.83%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 13,671.74 61 7.87%
2 Citi 12,076.06 76 6.95%
3 Morgan Stanley 11,899.85 66 6.85%
4 UBS 11,800.30 47 6.80%
5 Goldman Sachs 11,111.93 58 6.40%